We studied gene expression profiling of BCC tumour tissues coupled with laser capture microdissection to identify tumour specific receptor tyrosine kinase expression that can be targeted by small molecule inhibitors. This evidence concerns the gene NTRK1 and skin basal cell carcinoma.